Marc Wiesenberger
Stock Analyst at B. Riley Securities
(1.94)
# 1,723
Out of 4,667 analysts
34
Total ratings
69.57%
Success rate
61.15%
Average return
Main Sectors:
Stocks Rated by Marc Wiesenberger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMLR Semler Scientific | Downgrades: Neutral | $60 → $45 | $59.27 | -24.08% | 7 | Nov 2, 2022 | |
| OPRX OptimizeRx | Maintains: Buy | $71 → $56 | $4.42 | +1,166.97% | 1 | Jul 20, 2022 | |
| CLPT ClearPoint Neuro | Reinstates: Buy | $15 | $10.96 | +36.86% | 2 | Apr 5, 2022 | |
| AVGR Avinger | Maintains: Buy | $600 → $165 | $0.75 | +21,777.49% | 2 | Mar 18, 2022 | |
| OESX Orion Energy Systems | Downgrades: Neutral | $8.5 → $5 | $0.87 | +475.37% | 5 | Nov 10, 2021 | |
| ZYXI Zynex | Upgrades: Buy | $18 | $7.86 | +125.57% | 9 | Jul 16, 2021 | |
| NSIT Insight Enterprises | Maintains: Buy | $67 → $64 | $150.16 | -57.71% | 3 | May 11, 2020 | |
| LPTH LightPath Technologies | Maintains: Buy | $2.1 → $3.25 | $1.50 | +116.67% | 5 | May 8, 2020 |
Semler Scientific
Nov 2, 2022
Downgrades: Neutral
Price Target: $60 → $45
Current: $59.27
Upside: -24.08%
OptimizeRx
Jul 20, 2022
Maintains: Buy
Price Target: $71 → $56
Current: $4.42
Upside: +1,166.97%
ClearPoint Neuro
Apr 5, 2022
Reinstates: Buy
Price Target: $15
Current: $10.96
Upside: +36.86%
Avinger
Mar 18, 2022
Maintains: Buy
Price Target: $600 → $165
Current: $0.75
Upside: +21,777.49%
Orion Energy Systems
Nov 10, 2021
Downgrades: Neutral
Price Target: $8.5 → $5
Current: $0.87
Upside: +475.37%
Zynex
Jul 16, 2021
Upgrades: Buy
Price Target: $18
Current: $7.86
Upside: +125.57%
Insight Enterprises
May 11, 2020
Maintains: Buy
Price Target: $67 → $64
Current: $150.16
Upside: -57.71%
LightPath Technologies
May 8, 2020
Maintains: Buy
Price Target: $2.1 → $3.25
Current: $1.50
Upside: +116.67%